These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 18360024

  • 21. Poor hypertension control in Greek patients with diabetes in rural areas. The VANK study in primary care.
    Skliros E, Sotiropoulos A, Vasibossis A, Xipnitos C, Chronopoulos I, Razis N, Merkouris P.
    Rural Remote Health; 2007; 7(3):583. PubMed ID: 17617008
    [Abstract] [Full Text] [Related]

  • 22. Control of home heart rate and home blood pressure levels in treated patients with hypertension: the J-HOME study.
    Obara T, Ohkubo T, Komai R, Asayama K, Kikuya M, Metoki H, Inoue R, Murai K, Tanaka K, Hashimoto J, Totsune K, Imai Y, J-HOME study group.
    Blood Press Monit; 2007 Oct; 12(5):289-95. PubMed ID: 17890967
    [Abstract] [Full Text] [Related]

  • 23. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S, Lombardo M.
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [Abstract] [Full Text] [Related]

  • 24. The effect of age on hypertension control and management.
    Borzecki AM, Glickman ME, Kader B, Berlowitz DR.
    Am J Hypertens; 2006 May; 19(5):520-7. PubMed ID: 16647627
    [Abstract] [Full Text] [Related]

  • 25. Prehypertension and hypertension in a primary care practice.
    Godwin M, Pike A, Kirby A, Jewer C, Murphy L.
    Can Fam Physician; 2008 Oct; 54(10):1418-23. PubMed ID: 18854471
    [Abstract] [Full Text] [Related]

  • 26. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD, Kotovskaya YV, Villevalde SV, Moiseev VS, ARGUS-2 Study.
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [Abstract] [Full Text] [Related]

  • 27. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT, SCRIP-HTN Investigators.
    Arch Intern Med; 2008 Nov 24; 168(21):2355-61. PubMed ID: 19029501
    [Abstract] [Full Text] [Related]

  • 28. Geographical difference in the prevalence of isolated systolic hypertension in middle-aged men and women in Korea: the Korean Health and Genome Study.
    Kim BG, Park JT, Ahn Y, Kimm K, Shin C.
    J Hum Hypertens; 2005 Nov 24; 19(11):877-83. PubMed ID: 15988539
    [Abstract] [Full Text] [Related]

  • 29. Blood pressure control among Indians with hypertension: the I-Target survey.
    Hathial M.
    J Indian Med Assoc; 2007 Jul 24; 105(7):401-2, 404, 410. PubMed ID: 18178998
    [Abstract] [Full Text] [Related]

  • 30. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C.
    J Hypertens; 2008 Oct 24; 26(10):2064-70. PubMed ID: 18806632
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P, Woestenburg A, Brié H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I.
    Ann Pharmacother; 2009 May 24; 43(5):849-61. PubMed ID: 19351876
    [Abstract] [Full Text] [Related]

  • 32. Antihypertensive drug medication adherence and its affecting factors in South Korea.
    Park JH, Shin Y, Lee SY, Lee SI.
    Int J Cardiol; 2008 Aug 29; 128(3):392-8. PubMed ID: 17643514
    [Abstract] [Full Text] [Related]

  • 33. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC, Atkins R.
    Intern Med J; 2009 Mar 29; 39(3):143-9. PubMed ID: 18771428
    [Abstract] [Full Text] [Related]

  • 34. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May 29; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 35. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C, Ye X, Sung JC, Brixner DI, Kahler KH.
    Clin Ther; 2009 May 29; 31(5):1116-23. PubMed ID: 19539112
    [Abstract] [Full Text] [Related]

  • 36. Quality of sleep among hypertensive patients in a semi-urban Nigerian community: a prospective study.
    Alebiosu OC, Ogunsemi OO, Familoni OB, Adebayo PB, Ayodele OE.
    Postgrad Med; 2009 Jan 29; 121(1):166-72. PubMed ID: 19179828
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of hypertension without anti-hypertensive medications and its association with social demographic characteristics among 40 years and above adult population in Indonesia.
    Setiati S, Sutrisna B.
    Acta Med Indones; 2005 Jan 29; 37(1):20-5. PubMed ID: 15986551
    [Abstract] [Full Text] [Related]

  • 38. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J, Ceypová K, Kristenová P, Hauser T.
    Vnitr Lek; 2008 Nov 29; 54(11):1031-8. PubMed ID: 19069675
    [Abstract] [Full Text] [Related]

  • 39. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 29; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 40. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul 29; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.